Skip to content

A phase III study on the anti-SSI effects of preoperative immunonutrition for patients who undergo total gastrectomy for gastric cancer (OGSG 0507)

A phase III study on the anti-SSI effects of preoperative immunonutrition for patients who undergo total gastrectomy for gastric cancer - OGSG 0507

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000648
Enrollment
240
Registered
2007-04-01
Start date
2005-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo total gastrectomy for gastric cancer

Interventions

Group A: Inpact + free food intake Inpact 1000ml/day during preoperative 5 days and free food intake remorize about Inpact intake and administration of antibiotics Group B: Free fo

Sponsors

Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. gastric cancer confirmed by endoscopy and histology 2. required the total gastrectomy 3. with a scheduled day for surgical operation 4. patient who can take the immunonutrient for preoperative 5 days 5. without severe weight loss (within -10%) 6. with sufficient function on the liver, kidney and bone marrow 7. age 20<= and 80>= 8. written informed consent

Exclusion criteria

Exclusion criteria: 1. with other severe diseases 2. with some obstruction and/or bleeding on digestive tract 3. with active infectious diseases 4. patient who needs emergent operation 5. patient under some organ failure 6. uncontrolled DM or insulin controlled DM 7. without agreement of doctor

Design outcomes

Primary

MeasureTime frame
primary endpoint incidence of SSI secondary endpoints incidence of infection postoperative CRP postoperative complications

Countries

Japan

Contacts

Public ContactFurukawa Hiroshi

Sakai City Hospital Director

hfuruk@pop07.oden.ne.jp0722-21-1700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026